Equities analysts forecast that Agilent Technologies Inc (NYSE:A) will report earnings per share of $0.58 for the current fiscal quarter, according to Zacks Investment Research. Seven analysts have issued estimates for Agilent Technologies’ earnings, with estimates ranging from $0.57 to $0.62. Agilent Technologies reported earnings per share of $0.53 during the same quarter last year, which suggests a positive year-over-year growth rate of 9.4%. The business is expected to issue its next quarterly earnings results after the market closes on Wednesday, February 14th.
On average, analysts expect that Agilent Technologies will report full year earnings of $2.58 per share for the current financial year, with EPS estimates ranging from $2.54 to $2.68. For the next year, analysts expect that the company will post earnings of $2.88 per share, with EPS estimates ranging from $2.77 to $2.97. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research firms that that provide coverage for Agilent Technologies.
Agilent Technologies (NYSE:A) last issued its earnings results on Monday, November 20th. The medical research company reported $0.67 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.05. The company had revenue of $1.19 billion during the quarter, compared to the consensus estimate of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. Agilent Technologies’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.59 EPS.
In other Agilent Technologies news, VP Mark Doak sold 4,154 shares of the stock in a transaction dated Tuesday, December 5th. The shares were sold at an average price of $67.00, for a total transaction of $278,318.00. Following the completion of the transaction, the vice president now owns 68,270 shares of the company’s stock, valued at approximately $4,574,090. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Michael R. Mcmullen sold 22,481 shares of the stock in a transaction dated Friday, November 17th. The shares were sold at an average price of $68.77, for a total transaction of $1,546,018.37. Following the transaction, the chief executive officer now directly owns 336,637 shares of the company’s stock, valued at approximately $23,150,526.49. The disclosure for this sale can be found here. Insiders have sold a total of 219,991 shares of company stock valued at $15,468,795 in the last three months.
Several large investors have recently made changes to their positions in the stock. Victory Capital Management Inc. lifted its holdings in shares of Agilent Technologies by 8.2% in the 3rd quarter. Victory Capital Management Inc. now owns 3,330,488 shares of the medical research company’s stock valued at $213,817,000 after acquiring an additional 253,250 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in shares of Agilent Technologies by 5.8% in the 4th quarter. Wells Fargo & Company MN now owns 2,311,198 shares of the medical research company’s stock valued at $154,781,000 after acquiring an additional 126,696 shares during the last quarter. Impax Asset Management LTD lifted its holdings in shares of Agilent Technologies by 14.9% in the 3rd quarter. Impax Asset Management LTD now owns 2,106,322 shares of the medical research company’s stock valued at $135,226,000 after acquiring an additional 272,571 shares during the last quarter. Legal & General Group Plc lifted its holdings in shares of Agilent Technologies by 2.9% in the 3rd quarter. Legal & General Group Plc now owns 1,690,240 shares of the medical research company’s stock valued at $108,512,000 after acquiring an additional 46,962 shares during the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its holdings in shares of Agilent Technologies by 1.4% in the 3rd quarter. Schwab Charles Investment Management Inc. now owns 1,332,267 shares of the medical research company’s stock valued at $85,532,000 after acquiring an additional 18,189 shares during the last quarter.
Agilent Technologies (NYSE:A) opened at $65.05 on Friday. The firm has a market cap of $21,984.60, a price-to-earnings ratio of 30.98, a P/E/G ratio of 2.05 and a beta of 1.28. The company has a quick ratio of 2.85, a current ratio of 3.30 and a debt-to-equity ratio of 0.37. Agilent Technologies has a 1-year low of $50.00 and a 1-year high of $75.00.
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, January 24th. Shareholders of record on Tuesday, January 2nd were issued a dividend of $0.149 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.92%. The ex-dividend date was Friday, December 29th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.13. Agilent Technologies’s dividend payout ratio is 28.57%.
WARNING: This news story was first reported by American Banking News and is the property of of American Banking News. If you are reading this news story on another site, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2018/02/09/zacks-brokerages-anticipate-agilent-technologies-inc-a-will-announce-earnings-of-0-58-per-share.html.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.